Chuen Yan Cheng

Chuen Yan Cheng (Chinese: 鄭泉恩) is a Senior Scientist for the Population Council's Center for Biomedical Research. He is most well known as the inventor of the non-steroid male contraceptive drug——Adjudin,[1][2][3][4] which is the first male contraceptive drug on the market now finished clinical trials showing no side effects.[5][6]

Prof Chuen Yan Cheng
Born (1954-06-18) June 18, 1954
Hong Kong, China
NationalityUnited States
Alma materChinese University of Hong Kong (B.Sc.)
University of Newcastle, Australia (Ph.D.)
Known forMale contraceptive drug
AwardsRichard E. Weizman Memorial Award
Best Scientific Paper Award
Scientific career
FieldsBiochemistry
InstitutionsRockefeller University

Career

He graduated from the Chinese University of Hong Kong with a B.Sc. in 1977, and obtained his Ph.D. in biochemistry and cell biology at the University of Newcastle, Australia, in 1981. He came to New York as a Population Council post-doctoral trainee in 1981, studying in the laboratory of Drs. Wayne Bardin, Neal Musto, and Glen Gunsalus and was appointed as a research investigator in December 1982.

Cheng's research focuses on the development of a novel contraceptive for human males. These studies currently are supported by grants from the National Institutes of Health, the CONRAD Program, and the Andrew Mellon Foundation.

References
  1. "Obsessed Scientist Finally Throttles 'Em! Non-Paternity Potion". The New York Observor. Retrieved 2008-09-28.
  2. "Future male "pill" targets testicles". Retrieved 2008-09-28.
  3. "Male pill - Science Base". Retrieved 2008-09-28.
  4. "Seed: The Hunt for Male Birth Control". Retrieved 2008-09-28.
  5. "Trials for alternative male Pill show no side-effects". Retrieved 2008-09-28.
  6. "Male Contraceptive Drug in the Works". Retrieved 2008-09-28.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.